Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy

American Journal of Epidemiology

Volumn 151, Issue 1, 2000, Pages 57-62

  Li, De Kun ^a   Wi, Soora ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

HLA antigens; Paternity; Preeclampsia; Risk factors; Vital statistics

Indexed keywords

HLA ANTIGEN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ECLAMPSIA; FEMALE; HUMAN; NORMAL HUMAN; PATERNITY; PREECLAMPSIA; PREGNANCY; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0033927805     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010122     Document Type: Article

References (33)

1. Cunningham FG, MacDonald PC, Gant NF. Hypertensive disorders in pregnancy. In: Cunningham FG, MacDonald PC, Gant NF, et al., eds. Williams obstetrics. 19th ed. Norwalk, CT: Appleton & Lange, 1993:763-808.
2. Berg CJ, Atrash HK, Koonin LM, et al. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:161-7.
3. Kaunitz AM, Hughes JM, Grimes KA, et al. Causes of maternal mortality in the United States. Obstet Gynecol 1985;65: 605-12.
4. Saftlas AF, Olson DR, Franks AL, et al. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990;163:460-5.
5. Feeney JG, Scott JS. Pre-eclampsia and changed paternity. Eur J Obstet Gynecol Reprod Biol 1980;11:35-8.
6. Robillard PY, Hulsey TC, Alexander GR, et al. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol 1993;24:1-12.
7. Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 1996;7: 240-4.
8. Robillard PY, Hulsey TC. Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception (Letter; Comment). Lancet 1996;347:619.
9. Lie RT, Rasmussen S, Brunborg H, et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998;316:1343-7.
10. Klonoff-Cohen HS, Savitz DA, Cefalo RC, et al. An epidemiologic study of contraception and preeclampsia. JAMA 1989; 262:3143-7.
11. Robillard PY, Hulsey TC, Perianin J, et al. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994;344:973-5.
12. Scott JR. Hypertensive disorders of pregnancy. In: Scott JR, Disaia PJ, Hammond CB, et al., eds. Danforth's obstetrics and gynecology. Philadelphia, PA: J. B. Lippincott Co., 1994: 489-500.
13. Beer AE. Immunology of reproduction. In: Samter M, Talmage DW, Frank MM, et al., eds. Immunological diseases. Boston, MA: Little, Brown & Co., 1988:329-60.
14. Faulk WP, Coulam CB, McIntyre JA. Recurrent pregnancy loss. In: Machelle M, ed. Infertility: a comprehensive text. Norwalk, CT: Appleton & Lange, 1990:273-84.
15. Ober C. HLA and pregnancy: the paradox of the fetal allograft. Am J Hum Genet 1998;62:1-5.
16. Gill TJ III. Role of the major histocompatibility complex region in reproduction, cancer, and autoimmunity. Am J Reprod Immunol 1996;35:211-15.
17. Ober CL, Hauck WW, Kostyu DD, et al. Adverse effects of human leukocyte antigen-DR sharing on fertility: a cohort study in a human isolate. Fertil Steril 1985;44:227-32.
18. Scott JR, Rote NS, Branch DW. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987;4:645-56.
19. Ober C, Simpson JL, Ward M, et al. Prenatal effects of maternal-fetal HLA compatibility. Am J Reprod Immunol Microbiol 1987;15:141-9.
20. Hoff C, Peevy KJ, Spinnato JA, et al. Association between maternal-fetal HLA-DR relationships and fetal growth. Am J Reprod Immunol 1993;30:246-53.
21. Cowan LD, Hudson L, Bobele G, et al. Maternal-fetal HLA sharing and risk of newborn encephalopathy and seizures: a pilot study. J Child Neurol 1994;9:173-7.
22. The Recurrent Miscarriage Immunotherapy Trialists Group, Coulam CB, Clark DA, et al. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group. Am J Reprod Immunol 1994;32:55-72.
23. Gatenby PA, Cameron K, Simes RJ, et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol 1993;29:88-94.
24. Check JH, Tarquini P, Gandy P, et al. A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters. Gynecol Obstet Invest 1995;39:257-61.
25. Beer AE, Need JA. Immunological aspects of preeclampsia/ eclampsia. Birth Defects Orig Artic Ser 1985;21:131-54.
26. Kilpatrick DC, Liston WA, Jazwinska EC, et al. Histocompatibility studies in pre-eclampsia. Tissue Antigens 1987;29:232-6.
27. Kilpatrick DC, Gibson F, Livingston J, et al. Pre-eclampsia is associated with HLA-DR4 sharing between mother and fetus. Tissue Antigens 1990;35:178-81.
28. Bolis PF, Bianchi MM, La Fianza A, et al. Immunogenetic aspects of preeclampsia. Biol Res Preg 1987;8:42-5.
29. Kilpatrick DC, Liston WA, Gibson F, et al. Association between susceptibility to pre-eclampsia within families and HLA DR4. Lancet 1989;2:1063-5.
30. Schneider K, Knutson F, Tamsen L, et al. HLA antigen sharing in preeclampsia. Gynecol Obstet Invest 1994;37:87-90.
31. Redman CWG, Bodmer WF, Bodmer JG, et al. HLA antigens in severe pre-eclampsia. Lancet 1978;2:397-9.
32. Wilton AN, Barendse WJ, Donald JA, et al. HLA-DRB types in pre-eclampsia and eclampsia. Tissue Antigens 1991;38: 137-41.
33. Herman AA, McCarthy BJ, Bakewell JM, et al. Data linkage methods used in maternally-linked birth and infant death surveillance data sets from the United States (Georgia, Missouri, Utah and Washington State), Israel, Norway, Scotland and Western Australia. Paediatr Perinat Epidemiol 1997;11 (Suppl. 1):5-22.